Keyword Suggestion
Domain Informations
Andexxa.com lookup results from whois.comlaude.com server:
- Domain created: 2015-07-27T18:38:18Z
- Domain updated: 2024-03-28T06:43:05Z
- Domain expires: 2025-07-27T18:38:18Z 1 Year, 23 Days left
- Website age: 8 Years, 342 Days
- Registrar Domain ID: 1949513011_DOMAIN_COM-VRSN
- Registrar Url: http://www.comlaude.com
- Registrar WHOIS Server: whois.comlaude.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: +442074218250
- Name server:
- NS-1229.AWSDNS-25.ORG
- NS-154.AWSDNS-19.COM
- NS-1775.AWSDNS-29.CO.UK
- NS-979.AWSDNS-58.NET
Network
- inetnum : 13.32.0.0 - 13.33.255.255
- name : AMAZO-CF
- handle : NET-13-32-0-0-2
- status : Reallocated
- created : 1995-01-23
- changed : 2022-09-30
Owner
- organization : Amazon.com, Inc.
- handle : AMAZON-4
- address : Array,SEATTLE,WA,98101-1244,US
Abuse
- handle : AEA8-ARIN
- name : Amazon EC2 Abuse
- phone : +1-206-555-0000
- email : [email protected]
Technical support
- handle : ANO24-ARIN
- name : Amazon EC2 Network Operations
- phone : +1-206-555-0000
- email : [email protected]
Domain Provider | Number Of Domains |
---|---|
godaddy.com | 286730 |
namecheap.com | 101387 |
networksolutions.com | 69118 |
tucows.com | 52617 |
publicdomainregistry.com | 39120 |
whois.godaddy.com | 32793 |
enomdomains.com | 23825 |
namesilo.com | 21429 |
domains.google.com | 21384 |
cloudflare.com | 20573 |
gmo.jp | 18110 |
name.com | 17601 |
fastdomain.com | 14708 |
register.com | 13495 |
net.cn | 12481 |
ionos.com | 12416 |
ovh.com | 12416 |
gandi.net | 12305 |
registrar.amazon.com | 12111 |
Host Informations
- IP address: 13.32.151.99
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Timezone: America/Los_Angeles
Site Inspections
Port Scanner (IP: 13.32.151.99)
Spam Check (IP: 13.32.151.99)
Recent Searched Sites
› Rionet.jp (13 seconds ago) / JP
› Zygote.cafe (35 seconds ago) / US
› Data.tjj.cq.gov.cn (23 seconds ago) / CN
› Sysgar.com (19 seconds ago) / US
› Dominican-republic-properties-fsbo.com (1 seconds ago) / BR
› Aeortho.com (50 seconds ago) / US
› Arcade.software (32 seconds ago) / US
› Acetv.org (9 seconds ago) / US
› Bshb.in (30 seconds ago) / US
› Lomejordemilugar.abc.gob.ar (3 seconds ago) / AR
› Equipfoods.com (13 seconds ago) / CA
› Teachprivacy.com (21 seconds ago) / US
› Keystonedentistry.com (22 seconds ago) / US
› Ruggierolawfirm.com (34 seconds ago) / US
› Casasempereabogados.com (53 seconds ago) / US
› Ibnaljawzi.com (8 seconds ago) / US
› Onlinebanktours.com (40 seconds ago) / US
› Ibisfab.com (31 seconds ago) / CA
› Andexxa.com (0 seconds ago) / US
› M.sanmin.com.tw (2 seconds ago) / TW
Websites Listing
We found Websites Listing below when search with andexxa.com on Search Engine
Andexxa reverses anticoagulant-based bleeding events.
ANDEXXA (coagulation factor Xa (recombinant), inactivated-zhzo) is a recombinant modified human factor Xa (FXa) protein indicated for patients treated with rivaroxaban or apixaban, when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding. 1 This indication is approved under accelerated approval based on the change from baseline in anti …
Andexxa.comKey Points to Consider When Evaluating Andexxa for ...
2019-11-06 · Andexxa is a modified form of human Factor Xa which works by acting as a decoy that binds to factor Xa (FXa) inhibitors. It has been shown in vitro to rapidly reduce anti-FXa activity. The half-life of Andexxa is far shorter than the FXa inhibitors. Because of the short duration of action, anti-FXa activity starts to resume to baseline after ...
Neurocriticalcare.orgEMCrit 258 - Should Andexxa be added to a Hospital's ...
2019-10-26 · Original Release: October 26, 2019. Date of Most Recent Review: Jan 1, 2022. Termination Date: Jan 1, 2025. You finished the 'cast, Now Join EMCrit!
Emcrit.orgMarch 2022 - When will the ANDEXXA patents expire, and ...
2022-03-21 · 1) High Certainty: US Patents for ANDEXXA Derived from Brand-Side Litigation. No patents found based on brand-side litigation. 2) High Certainty: US Patents for ANDEXXA Derived from Company Disclosures. No patents found based on company disclosures. 3) Low Certainty: US Patents for ANDEXXA Derived from Patent Text Search
Drugpatentwatch.comReversing Direct Oral Anticoagulants With Andexxa | The ...
2019-12-17 · Andexxa is very expensive. Old literature showed a single dose price of $49,500 but this has been revised downward. Effective in October 2019, Medicare agreed to reimburse a hospital about $18,000 for Andexxa over and above the DRG for the patient’s care. Remember, due to the half life of the Factor Xa inhibitors, two doses may be needed.
Thetraumapro.comDailyMed - ANDEXXA- andexanet alfa injection, powder ...
2022-04-05 · 400 mg at a target rate of 30 mg/min. 4 mg/min for up to 120 minutes. High Dose. 800 mg at a target rate of 30 mg/min. 8 mg/min for up to 120 minutes. DOSAGE FORMS AND STRENGTHS. ANDEXXA is available as a lyophilized powder in single-use vials of 200 mg of coagulation factor Xa (recombinant), inactivated-zhzo.
Dailymed.nlm.nih.govANDEXXA (coagulation factor Xa (recombinant), inactivated ...
2019-06-28 · ANDEXXA (coagulation factor Xa (recombinant), inactivated-zhzo) STN: BLA 125586. Proper Name: coagulation factor Xa (recombinant), inactivated-zhzo. Trade Name: ANDEXXA. Manufacturer: Portola ...
Fda.govAndexxa effective in GI bleeds - Healio
2019-11-19 · “[Andexxa (andexanet alfa, Portola) is a recombinant modified human factor Xa molecule that was specifically designed to reverse the effects of factor Xa inhibitor anticoagulants,” Deborah ...
Healio.comANNEXA-4: Andexanet Alfa and Factor Xa Inhibitors - REBEL EM
2019-03-04 · Andexanet Alfa, a Novel Antidote to the anticoagulation Effects of Factor Xa Inhibitors (ANNEXA-4): In May of 2018, Andexanet alfa gained accelerated approval by the FDA for the reversal of Factor Xa Inhibitors, but robust evidence in its support have been lacking.
Rebelem.comANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
2 This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse
Ema.europa.euBuy Ondexxya (andexanet alfa) Online • Price & Costs ...
Ondexxya (andexanet alfa) is a medication used for the treatment of patients treated with rivaroxaban or apixaban, when reversal of anticoagulation is needed due to life-threatening or uncontrolled bleeding. This is the first approved antidote for apixaban- or rivaroxaban-treated patients with uncontrolled bleeds. Ondexxya (andexanet alfa) was approved by the FDA in …
Thesocialmedwork.comFull Study Report of Andexanet Alfa for Bleeding ...
2019-02-07 · Abstract Background Andexanet alfa is a modified recombinant inactive form of human factor Xa developed for reversal of factor Xa inhibitors. Methods We evaluated 352 patients who had acute major b...
Nejm.orgOndexxya 200 mg powder for solution for infusion - Summary ...
2021-10-27 · Ondexxya 200 mg powder for solution for infusion. 2. Qualitative and quantitative composition. Each vial contains 200 mg of andexanet alfa*. After reconstitution, each mL of solution contains 10 mg of andexanet alfa. * Andexanet alfa is produced by recombinant DNA technology in Chinese Hamster Ovary (CHO) cells.
Medicines.org.ukReversal of Heparin-Induced Anticoagulation By Andexanet ...
2015-12-03 · Background: Unfractionated heparin is used in the management of venous thromboembolism, stroke prevention in atrial fibrillation as well as in cardiac surgeries (e.g., valve replacement and other procedures requiring cardiopulmonary bypass). Bleeding is the major complication that may result from these therapies. Although protamine sulfate can be used to …
Ashpublications.orgSections or subsections omitted from the Full Prescribing ...
ANDEXXA, 223 received at least one anticoagulation dose within 30 days after treatment. Of these 223, 18 subjects (8%) had a thrombotic event and/or ischemic event after resumption. Monitor subjects treated with ANDEXXA for signs and symptoms of arterial and venous
Alexion.comAndexxa Enters Guidelines for Bleeding on Oral ...
2020-07-14 · email article. Recently-approved treatments prompted an update to American College of Cardiology (ACC) guidance on managing bleeding in patients on oral anticoagulation. ... (Andexxa), approved in ...
Medpagetoday.com(coagulation factor Xa (recombinant), inactivated-zhzo)
ANDEXXA (coagulation factor Xa (recombinant), inactivated-zhzo) is a recombinant modified human factor Xa (FXa) protein indicated for patients treated with rivaroxaban or apixaban, when reversal of anticoagulation is needed due ... [Alexion Rep Email] Program Details Date:
Go.beckershospitalreview.comEvaluation of andexanet alfa and ... - Wiley Online Library
2020-04-15 · Background/Objective Before approval of andexanet alfa, off-label treatment with 4-factor prothrombin complex concentrate (4F-PCC) was often utilized for the management of life-threatening hemorrhag...
Onlinelibrary.wiley.comAndexxa® - cdn.ymaws.com
ANDEXXA has not been shown to be effective for, and is not indicated for, the treatment of bleeding related to any FXa inhibitors other than apixaban and rivaroxaban. BENJAMIN KALSMITH, MD, FACC PITTSBURGH, PA Vanessa Bronder 4122159680 [email protected] TUESDAY, MARCH 12, 2019
Cdn.ymaws.comAndexxa - RxList
2022-02-11 · Common side effects of coagulation factor Xa may include: lung problems; painful urination; or. pain, swelling, burning, or irritation around the IV needle. This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Rxlist.com
Domains Expiration Date Updated
Site | Provider | Expiration Date |
---|---|---|
jowomenomics.org | whois.godaddy.com | -2 Years, -77 Days |
mpclawsd.com | wildwestdomains.com | -2 Years, -44 Days |
paxosblue.com | papaki.com | 1 Year, 143 Days |
khannay.com | registrar.amazon.com | -1 Years, -188 Days |
bioquest.org | networksolutions.com | 3 Years, 214 Days |
sandjest.com | namecheap.com | -1 Years, -341 Days |
runkkaa.com | namecheap.com | 141 Days |
bintangsekolahindonesia.com | publicdomainregistry.com | -2 Years, -75 Days |
zametsa.com | publicdomainregistry.com | -1 Years, -258 Days |
gdgdocs.org | cloudflare.com | -2 Years, -26 Days |